This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Caris Life Sciences Switzerland Holdings Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of Daniel Holterman
Introduction
Daniel Holterman is an accomplished inventor based in Phoenix, AZ. He has made significant contributions to the field of theranostics through his innovative work on biomarkers. His research focuses on the assessment of biomarkers for diagnostic, therapy-related, and prognostic methods.
Latest Patents
Holterman holds a patent for "Biomarkers for Theranostics." This patent outlines the use of circulating biomarkers from bodily fluids to profile physiological states and determine phenotypes. These biomarkers include nucleic acids, proteins, and circulating structures such as vesicles. They can be utilized for theranostic purposes, aiding in the selection of treatment regimens for various diseases and conditions. The patent emphasizes the importance of these biomarkers in determining treatment efficacy.
Career Highlights
Holterman is associated with Caris Life Sciences Switzerland Holdings GmbH, where he continues to advance his research in the field of biomarkers. His work has the potential to revolutionize how diseases are diagnosed and treated, making significant strides in personalized medicine.
Collaborations
Some of his notable coworkers include David D Halbert and Michael Klass, who contribute to the innovative environment at Caris Life Sciences.
Conclusion
Daniel Holterman is a pioneering inventor whose work on biomarkers for theranostics is shaping the future of medical diagnostics and treatment. His contributions are vital in the ongoing quest for more effective and personalized healthcare solutions.